Cancer patients could be significantly disadvantaged by Brexit, say experts

Collaboration with Europe is key to future breakthroughs, say leading cancer experts including Nobel Prize winner Paul Nurse British cancer patients could be left "significantly disadvantaged" by the UK's departure from the EU, leading oncologists have said, as collaboration with European scientists has been vital to making breakthroughs in the field. In an editorial published on Friday in the journal ecancermedicalscience, six doctors, representing cancer physicians, patient advocacy groups and...